How many listed companies produce animal vaccines for China?

Avian influenza vaccine listed companies:

1.？ Zhongmu Co., Ltd. (600 195.sh), the company's main products include poultry vaccines, veterinary vaccines and special vaccines. The annual output of animal vaccines exceeds 20 billion feathers, accounting for more than one third of the national market; The company's PRRS vaccine is produced by Chengdu Medical Machinery Factory and Nanjing Bio-pharmaceutical Factory, which is a subsidiary of Ganyuanhao Bio-holding Company, and both of them are among the 12 highly pathogenic PRRS vaccine manufacturers approved by the Ministry of Agriculture. The company's avian influenza vaccine has formed a production capacity of 654.38+03 billion feathers, and the gross profit margin of the products has reached 60%. The main producers of avian influenza vaccine are Nanjing Meilia, accounting for 50% of the company's shares, and Ganyuanhao Bio, accounting for 52.92% of the company's shares. These two enterprises are one of the designated production enterprises of nine poultry influenza vaccines officially approved by the Ministry of Agriculture. Nanjing Meilia, a subsidiary of the company, sold foot-and-mouth disease vaccine 1005438+0 billion ml in 2009; China Animal Husbandry Co., Ltd. also produces porcine pseudorabies inactivated vaccine and porcine pseudorabies gene deletion vaccine, and has the first pet vaccine factory in China.

2.？ Zhejiang Pharmaceutical (6002 16.sh) has developed a new avian influenza drug, which belongs to neuraminidase inhibitor, which can effectively inhibit the neuraminidase of avian influenza virus strains, and can also be used to treat a wide range of influenza caused by the redistribution of avian influenza virus strains.

3.？ Shenghua Encyclopedia (600226.sh), the company's main business includes biochemical veterinary pesticides business. Biological pesticides and veterinary drugs are the main profit sources of the company, and the products include avermectin, dicamba, colistin sulfate and flavomycin. Qingdao Yibang Bioengineering, holding 38% of the shares, is a designated production enterprise of avian influenza vaccine officially approved by the Ministry of Agriculture. Its products are mainly H9 subtype avian influenza inactivated vaccine, H5 and H9 bivalent avian influenza inactivated vaccine.

4.？ Jinyu group

Listed companies of porcine blue ear disease vaccine:

1.？ Zhongmu stock

2.？ Jinyu group

Listed companies of foot-and-mouth disease vaccine:

1.？ Jinyu Group (60020 1.sh), the only national engineering laboratory for veterinary vaccines in China, has developed genetic engineering vaccines for seven zoonotic diseases such as pig foot-and-mouth disease virus gene recombination; Inner Mongolia Biopharmaceutical Factory under the company is the only enterprise that produces veterinary vaccine products in Inner Mongolia Autonomous Region, and it is also a special veterinary vaccine manufacturer designated by the Ministry of Agriculture, mainly producing avian influenza vaccine; Yangzhou AIA Biopharmaceutical Co., Ltd., which holds 100% equity, is the base of Jinyu Group to produce inactivated vaccine of porcine reproductive and respiratory syndrome (porcine blue ear disease), with an estimated production capacity of 300 million ml/year; The company's biopharmaceutical factory has 2.4 billion milliliters of foot-and-mouth disease vaccine (the largest in China), accounting for 90% of its main business.

2.？ Tiankang Bio (002 100.sz) is the third largest foot-and-mouth disease vaccine manufacturer in China, in which the market share of foot-and-mouth disease vaccine for cattle and sheep reaches16%; The company cooperated with Shanghai Youbixuan Biotechnology to develop bivalent synthetic peptide vaccine for foot-and-mouth disease in cattle and sheep. The company plans to complete 600 million milliliters of foot-and-mouth disease vaccine and 60 million doses of swine fever vaccine in 20 10.

3.？ Zhongmu stock

Porcine pseudorabies vaccine:

1.？ Huashen Group (000790.sz), the company's veterinary products mainly include live porcine pseudorabies vaccine, and its wholly-owned subsidiary, Sichuan Huashen Animal Biological Products, produces live porcine pseudorabies vaccine (SA2 15 strain), which is the first animal virus genetic engineering vaccine with completely independent intellectual property rights in China.

2.？ Zhongmu stock

Veterinary drug listed companies:

1.？ Qianjiang Biochemical Co., Ltd. (600796.sh) is a listed company mainly engaged in research and development, production and sales of biological pesticides, biological veterinary drugs and biomedical intermediates. It is an important pesticide production base in China. The company's veterinary drug product colistin sulfate is an effective veterinary drug for Salmonella and an effective therapeutic product in the field of "super bacteria" veterinary drugs.

2.？ Donghu High-tech (600 133.sh), a subsidiary of Wuhan Zhongbo Shenghua, specializes in veterinary vaccines, veterinary drugs and fishery drugs. And has an animal vaccine production base that meets GMP standards.

3.？ Rip Bio (300 1 19.sz) focuses on the field of veterinary drugs. Its products are mainly suitable for poultry and livestock such as chickens and pigs, and keep a leading position in many technical fields such as heat-resistant protection technology of live vaccine, ultrafiltration concentration technology of inactivated vaccine, vaccine strain breeding, immune enhancer, new drug dosage form and so on.

4.？ Xianghai Pharmaceutical Co., Ltd. (002009.sz), the company's veterinary drug raw material flunixin meglumine salt can be used to relieve inflammation and pain caused by horse muscle abnormality, and can also be used to treat pig diarrhea. At present, the company has obtained the COS certificate and European sales license for this product.